Harvard Bioscience (NASDAQ:HBIO) filed for $100M mixed securities shelf. This preliminary prospectus is not an offer to sell. Filing
More on Harvard Bioscience
Seeking Alpha's Quant Rating on Harvard Bioscience Historical earnings data for Harvard Bioscience Financial information for Harvard Bioscience